4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001493152-19-003805
Options or other derivatives
- Chief Financial Officer acquired 41,667 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Arrow Alexander K. Chief Financial Officer | 2019-03-20 | Grant or award · PTIX Common stock Options | +41,667 | 41,667 | D | ||
Loading xslF345X03/ownership.xml…